SPARK THERAPEUTICS, INC. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fee05817-49a9-449f-9026-d3928e3aeabe/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $64.7M | 2018-01-01 – 2018-12-31 | evidence 0001609351-19-000042 |
| FY 2017 | $12.1M | 2017-01-01 – 2017-12-31 | evidence 0001609351-19-000042 |
| FY 2016 | $20.2M | 2016-01-01 – 2016-12-31 | evidence 0001609351-19-000042 |
| FY 2015 | $22.1M | 2015-01-01 – 2015-12-31 | evidence 0001609351-16-000020 |
| FY 2014 | $633.9k | 2014-01-01 – 2014-12-31 | evidence 0001609351-16-000020 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SPARK THERAPEUTICS, INC. — all facts · Net Income · Operating Income